APA (7th ed.) Citation

Zhao J, Hao S, Tian J, Li Y, & Han D. (2023). Comparison of Neoadjuvant Immunotherapy Plus Chemotherapy versus Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score Matching Study. Dove Medical Press.

Chicago Style (17th ed.) Citation

Zhao J, Hao S, Tian J, Li Y, and Han D. Comparison of Neoadjuvant Immunotherapy Plus Chemotherapy Versus Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score Matching Study. Dove Medical Press, 2023.

MLA (9th ed.) Citation

Zhao J, et al. Comparison of Neoadjuvant Immunotherapy Plus Chemotherapy Versus Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score Matching Study. Dove Medical Press, 2023.